CELZ (STOCKS)
Creative Medical Technology Holdings, Inc. Common Stock
$2.220000
+0.080000 (+3.74%)
Prev close: $2.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Timothy Warbington
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.91M
- Employees
- 4
- P/E (TTM)
- -0.95
- P/B (TTM)
- 1.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.48 | $-0.49 | +0.0096 | +1.96% |
|
Jun 2025 (Q2)
|
$-0.48 | $-0.64 | +0.1626 | +25.30% |
|
Mar 2025 (Q1)
|
$-0.83 | $-0.53 | -0.2996 | -56.49% |
|
Dec 2024 (Q4)
|
$-1.12 | $-0.64 | -0.4774 | -74.29% |
Financial Statements
| Revenues | $6.00K |
| Benefits Costs and Expenses | $6.00M |
| Cost Of Revenue | $2.19K |
| Costs And Expenses | $6.00M |
| Gross Profit | $3.81K |
| Nonoperating Income/Loss | $147.81K |
| Operating Expenses | $6.15M |
| Selling, General, and Administrative Expenses | $3.76M |
| Research and Development | $2.26M |
| Other Operating Expenses | $123.33K |
| Operating Income/Loss | -$6.14M |
| Income/Loss From Continuing Operations After Tax | -$6.00M |
| Income/Loss From Continuing Operations Before Tax | -$6.00M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$6.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Earnings Per Share | -$2.52 |
| Diluted Average Shares | 2,382,797 |
| Assets | $7.81M |
| Current Assets | $7.40M |
| Inventory | $0.00 |
| Noncurrent Assets | $410.51K |
| Liabilities | $284.88K |
| Current Liabilities | $284.88K |
| Accounts Payable | $270.69K |
| Other Current Liabilities | $14.19K |
| Noncurrent Liabilities | $0.00 |
| Equity | $7.52M |
| Equity Attributable To Noncontrolling Interest | $10.00K |
| Equity Attributable To Parent | $7.51M |
| Liabilities And Equity | $7.81M |
| Net Cash Flow From Operating Activities | -$5.86M |
| Net Cash Flow From Operating Activities, Continuing | -$5.86M |
| Net Cash Flow From Investing Activities | -$50.50K |
| Net Cash Flow From Investing Activities, Continuing | -$50.50K |
| Net Cash Flow From Financing Activities | $7.17M |
| Net Cash Flow From Financing Activities, Continuing | $7.17M |
| Net Cash Flow | $1.27M |
| Net Cash Flow, Continuing | $1.27M |
| Comprehensive Income/Loss | -$6.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.00M |
| Other Comprehensive Income/Loss | $0.00 |